NEW YORK, March 12, 2009 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq:ATMI), today announced it will feature the next-generation of its Nucleo(tm) Bioreactor and an array of advanced solutions for the pharmaceutical and biopharmaceutical manufacturing industries at the Jacob K. Javits Convention Center (Booth #1373) here on March 17-19, 2009.
Customer data from the Nucleo Bioreactor will be released publicly for the first time at INTERPHEX. Resulting from a close collaboration effort that aligned the single-use mixing expertise of Pierre Guerin with ATMI LifeSciences' know-how in ultra-clean films, the scalable bioreactor minimizes stresses on anchorage-dependent cultures while achieving new levels in high density cell line growth. (In the United States, the Nucleo BioReactor is marketed by ATMI LifeSciences and DCI-Biolafitte, under a joint venture of DCI and Pierre Guerin.)
ATMI LifeSciences executives and product experts will be on-site for interviews throughout the show. Spokespeople will be available to discuss the Nucleo system and industry topics such as:
* Bioprocess efficiency * Environmental implications of disposable bioreactors * New opportunities for high cell density applications * Evolution of disposable bioreactors * Disposable bioreactors' affect on the industry compared to traditional stainless steel * Real-world applications of disposable bioreactors in lab and production environments
About ATMI LifeSciences
ATMI LifeSciences is a leader in single-use mixing, storage, and bioreactor technology, fluoropolymer-based products, and custom-engineered, flexible packaging solutions. The Company's fundamental knowledge of polymers, specially selected resins, and its cleanroom manufacturing experience coalesce to help drive optimum performance in critical disposable process operations. For more information, please visit www.atmi-lifesciences.com.
ATMI and the ATMI logo are trademarks or registered trademarks of Advanced Technology Materials, Inc., in the United States, other countries or both. Nucleo is a trademark or registered trademark of Advanced Technology Materials, Inc., and Pierre Guerin in the United States, other countries or both. Patented and Patents Pending.
The ATMI, Inc. logo is available athttp://www.globenewswire.com/newsroom/prs/?pkgid=5254
Statements contained herein that relate to ATMI's future performance, including, without limitation, statements with respect to ATMI's anticipated results of operations or level of business for 2009 or any other future period, are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations only and are subject to certain risks, uncertainties, and assumptions, including, but not limited to, changes in semiconductor industry growth (including, without limitation, wafer starts) or ATMI's markets; competition, problems, or delays developing, commercializing and delivering new products; problems or delays in integrating acquired operations and businesses; uncertainty in the credit and financial markets; and other factors described in ATMI's Form 10-K for the year ended December 31, 2007, and other subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties may cause actual results to differ materially from those expressed in our forward-looking statements. ATMI undertakes no obligation to update any forward-looking statements.